GPN Vaccines is VC-Backed and has raised funding across Series B and Series A3 rounds.
Alternatives.pe tracks GPN Vaccines's funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Explore the latest updates and insights
GPN Vaccines Closes Oversubscribed AUD $18 million (USD $12 million) Series B1 Investment Round
GPN Vaccines Closes AUD$9 million (USD$6 million) Series A3 Investment Round
GPN Vaccines closes A$7 million Series A2 round oversubscribed with Forepont Capital Partners ... see summary
GPN Vaccines awarded $1 million from the South Australian Government
GPN VACCINES RAISES AUD$1.1M (USD$0.8M)
A view of the number of employees over time
Key members of the management team